Found: 28
Select item for more details and to access through your institution.
Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 12393, doi. 10.1007/s00432-023-04982-x
- By:
- Publication type:
- Article
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0947-4
- By:
- Publication type:
- Article
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.
- Published in:
- Molecular Cancer, 2018, v. 17, p. 1, doi. 10.1186/s12943-017-0755-z
- By:
- Publication type:
- Article
Ribosome profiling: a powerful tool in oncological research.
- Published in:
- Biomarker Research, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40364-024-00562-4
- By:
- Publication type:
- Article
Role of the microbiome in occurrence, development and treatment of pancreatic cancer.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-019-1103-2
- By:
- Publication type:
- Article
Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00586-x
- By:
- Publication type:
- Article
Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
- Published in:
- Cancer Medicine, 2019, v. 8, n. 14, p. 6403, doi. 10.1002/cam4.2384
- By:
- Publication type:
- Article
Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.596573
- By:
- Publication type:
- Article
Expression, function and clinical application of stanniocalcin‐1 in cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 14, p. 7686, doi. 10.1111/jcmm.15348
- By:
- Publication type:
- Article
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 3, p. 569, doi. 10.20892/j.issn.2095-3941.2020.0033
- By:
- Publication type:
- Article
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02050-7
- By:
- Publication type:
- Article
CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03201-w
- By:
- Publication type:
- Article
IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169038
- By:
- Publication type:
- Article
HIF‐1α‐regulated stanniocalcin‐1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 9, p. 839, doi. 10.1002/mc.23420
- By:
- Publication type:
- Article
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 497, doi. 10.3390/cells10030497
- By:
- Publication type:
- Article
A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy.
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 10, p. 938, doi. 10.1007/s00535-021-01818-8
- By:
- Publication type:
- Article
Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer.
- Published in:
- Cancer Management & Research, 2024, v. 16, p. 651, doi. 10.2147/CMAR.S465098
- By:
- Publication type:
- Article
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review.
- Published in:
- Cancer Communications, 2021, v. 41, n. 12, p. 1257, doi. 10.1002/cac2.12204
- By:
- Publication type:
- Article
Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/2340124
- By:
- Publication type:
- Article
Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.985184
- By:
- Publication type:
- Article
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 2, p. 361, doi. 10.1007/s13402-023-00872-z
- By:
- Publication type:
- Article
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1691, doi. 10.1007/s13402-023-00836-3
- By:
- Publication type:
- Article
CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 2, p. 345, doi. 10.1007/s13402-020-00569-7
- By:
- Publication type:
- Article
Targeting hypoxic tumor microenvironment in pancreatic cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01030-w
- By:
- Publication type:
- Article
Comparing the clinical value of baseline [<sup>68</sup> Ga]Ga-FAPI-04 PET/CT and [<sup>18</sup>F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 13, p. 4036, doi. 10.1007/s00259-023-06297-y
- By:
- Publication type:
- Article
Prognostic value of preoperative [<sup>68</sup> Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 6, p. 1780, doi. 10.1007/s00259-022-06100-4
- By:
- Publication type:
- Article
Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 8, p. 908, doi. 10.1093/bjs/znac375
- By:
- Publication type:
- Article
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-1147-9
- By:
- Publication type:
- Article